Importantly, EPO/EPOR levels correlated well with angiogenesis and progression of patients with hepatocellular, squamous cell of the tongue and non-small cell lung carcinomas, neuroblastoma, melanoma, and gastric adenocarcinoma [89,90,91,92,93,94,95]. Here, EPO is linked to non-small cell lung carcinoma.